BioAtla, Inc.(BCAB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BCAB BioAtla, Inc.

休市中 03-06 16:00:00 EST

0.1678

-0.0001

-0.06%

盘后0.1737

+0.0059+3.52%

19:41 EST

最高0.1700	最低0.1532	成交量122.73万
今开0.1532	昨收0.1679	日振幅10.01%
总市值1,246万	流通市值845.31万	总股本7,426万
成交额20.00万	换手率2.44%	流通股本5,038万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BCAB","market":"US","secType":"STK","nameCN":"BioAtla, Inc.","latestPrice":0.1678,"timestamp":1772830800000,"preClose":0.1679,"halted":0,"volume":1227313,"hourTrading":{"tag":"盘后","latestPrice":0.1737,"preClose":0.1678,"latestTime":"19:41 EST","volume":76475,"amount":13108.8824,"timestamp":1772844074967,"change":0.0059,"changeRate":0.035161,"amplitude":0.035757},"delay":0,"changeRate":-0.0005955926146515128,"floatShares":50376300,"shares":74263700,"eps":-1.149537,"marketStatus":"休市中","change":-0.0001,"latestTime":"03-06 16:00:00 EST","open":0.1532,"high":0.17,"low":0.1532,"amount":200017.80151356,"amplitude":0.10006,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.149537,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1773043200000},"marketStatusCode":7,"adr":0,"listingDate":1608094800000,"exchange":"NASDAQ","adjPreClose":0.1679,"preHourTrading":{"tag":"盘前","latestPrice":0.155,"preClose":0.1679,"latestTime":"09:29 EST","volume":108798,"amount":16782.59088282,"timestamp":1772807388402,"change":-0.0129,"changeRate":-0.076831,"amplitude":0.151281},"postHourTrading":{"tag":"盘后","latestPrice":0.1737,"preClose":0.1678,"latestTime":"19:41 EST","volume":76475,"amount":13108.8824,"timestamp":1772844074967,"change":0.0059,"changeRate":0.035161,"amplitude":0.035757},"volumeRatio":0.5048547659024732,"impliedVol":1.2986,"impliedVolPercentile":0.259},"requestUrl":"/m/hq/s/BCAB","defaultTab":"news","newsList":[{"id":"2616344423","title":"Bioatla, Inc.股价重挫22.03% 市值跌315.58万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616344423","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616344423?lang=zh_cn&edition=full","pubTime":"2026-03-02 22:34","pubTimestamp":1772462069,"startTime":"0","endTime":"0","summary":"北京时间2026年03月02日22时34分，Bioatla, Inc.股票出现波动，股价快速跳水22.03%。截至发稿，该股报0.193美元/股，成交量65.3014万股，换手率0.88%，振幅9.54%。Bioatla, Inc.股票所在的生物技术行业中，整体跌幅为0.26%。其相关个股中，Rallybio Corporation、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Xeris制药涨幅较大，Ensysce Biosciences, Inc.、Rallybio Corporation、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为76.04%、27.55%、22.15%，振幅较大的相关个股有Rallybio Corporation、Ensysce Biosciences, Inc.、Edesa Biotech, Inc.，振幅分别为15.52%、13.14%、12.27%。Bioatla, Inc.公司简介：BioAtla Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302223429a4428ec1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302223429a4428ec1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCAB","BK4139"],"gpt_icon":0},{"id":"2607909358","title":"Bioatla, Inc.盘中异动 股价大跌6.05%报0.292美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607909358","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607909358?lang=zh_cn&edition=full","pubTime":"2026-01-30 00:00","pubTimestamp":1769702402,"startTime":"0","endTime":"0","summary":"北京时间2026年01月30日00时00分，Bioatla, Inc.股票出现波动，股价大幅下跌6.05%。截至发稿，该股报0.292美元/股，成交量30.7811万股，换手率0.48%，振幅8.05%。Bioatla, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Briacell Therapeutics Corp C/Wts 、Serina Therapeutics, Inc.、Sangamo Therapeutics, Inc.涨幅较大，Serina Therapeutics, Inc.、Aspire Biopharma Holdings, Inc.、Aprea Therapeutics, Inc.较为活跃，换手率分别为552.67%、109.00%、72.47%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Biomx Inc.、Aprea Therapeutics, Inc.，振幅分别为104.32%、38.75%、27.75%。Bioatla, Inc.公司简介：BioAtla Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130000003953efad4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130000003953efad4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BCAB"],"gpt_icon":0},{"id":"2605528226","title":"Bioatla, Inc.盘中异动 股价大涨8.56%报0.348美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605528226","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605528226?lang=zh_cn&edition=full","pubTime":"2026-01-23 22:32","pubTimestamp":1769178733,"startTime":"0","endTime":"0","summary":"北京时间2026年01月23日22时32分，Bioatla, Inc.股票出现异动，股价急速拉升8.56%。截至发稿，该股报0.348美元/股，成交量65.6566万股，换手率1.03%，振幅4.22%。Bioatla, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。其相关个股中，Revelation Biosciences, Inc.、Coherus Oncology, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Revelation Biosciences, Inc.、60 Degrees Pharmaceuticals, Inc.、Sensei Biotherapeutics, Inc.较为活跃，换手率分别为358.77%、43.47%、11.38%，振幅较大的相关个股有Cyclerion Therapeutics, Inc.、Coherus Oncology, Inc.、Revelation Biosciences, Inc.，振幅分别为12.86%、8.81%、8.19%。Bioatla, Inc.公司简介：BioAtla Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123223213a6a58909&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123223213a6a58909&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BCAB"],"gpt_icon":0},{"id":"2604694908","title":"Bioatla, Inc.盘中异动 大幅拉升5.10%报0.336美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604694908","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604694908?lang=zh_cn&edition=full","pubTime":"2026-01-16 23:18","pubTimestamp":1768576715,"startTime":"0","endTime":"0","summary":"北京时间2026年01月16日23时18分，Bioatla, Inc.股票出现波动，股价大幅拉升5.10%。截至发稿，该股报0.336美元/股，成交量29.1424万股，换手率0.50%，振幅3.97%。Bioatla, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。其相关个股中，Jaguar Health, Inc.、Immunitybio, Inc.、Hcw Biologics Inc.涨幅较大，Jaguar Health, Inc.、Biodexa Pharmaceuticals Plc、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为1097.78%、112.29%、40.37%，振幅较大的相关个股有60 Degrees Pharmaceuticals, Inc.、Moolec Science Sa C/Wts 30/01/2028、Jaguar Health, Inc.，振幅分别为44.48%、27.83%、27.47%。Bioatla, Inc.公司简介：BioAtla Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116231835a7238413&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116231835a7238413&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BCAB"],"gpt_icon":0},{"id":"2603682648","title":"Bioatla, Inc.盘中异动 早盘急速拉升5.22%报0.324美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603682648","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603682648?lang=zh_cn&edition=full","pubTime":"2026-01-14 23:26","pubTimestamp":1768404400,"startTime":"0","endTime":"0","summary":"北京时间2026年01月14日23时26分，Bioatla, Inc.股票出现异动，股价快速上涨5.22%。截至发稿，该股报0.324美元/股，成交量99.9104万股，换手率1.70%，振幅7.20%。Bioatla, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Bioatla, Inc.公司简介：BioAtla Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114232640a71acf70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114232640a71acf70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCAB","BK4139"],"gpt_icon":0},{"id":"2603565570","title":"Bioatla, Inc.盘中异动 早盘股价大涨7.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603565570","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603565570?lang=zh_cn&edition=full","pubTime":"2026-01-13 22:33","pubTimestamp":1768314784,"startTime":"0","endTime":"0","summary":"北京时间2026年01月13日22时33分，Bioatla, Inc.股票出现异动，股价大幅拉升7.37%。截至发稿，该股报0.338美元/股，成交量22.0847万股，换手率0.38%，振幅3.97%。Bioatla, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Decoy Therapeutics Inc.、Briacell Therapeutics Corp.、Xtl生物制药涨幅较大，Scisparc Ltd.、Decoy Therapeutics Inc.、Briacell Therapeutics Corp.较为活跃，换手率分别为1069.43%、946.67%、246.32%，振幅较大的相关个股有Lexaria Bioscience Corp C/Wts 14/01/2026 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Decoy Therapeutics Inc.，振幅分别为30.19%、25.13%、24.54%。Bioatla, Inc.公司简介：BioAtla Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113223305a71640a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113223305a71640a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCAB","BK4139"],"gpt_icon":0},{"id":"1119252363","title":"BioAtla与GATC Health达成4000万美元特殊目的载体交易，推进Ozuriftamab Vedotin（Oz-V）进入2L+口咽鳞状细胞癌注册性临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1119252363","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119252363?lang=zh_cn&edition=full","pubTime":"2025-12-31 20:05","pubTimestamp":1767182707,"startTime":"0","endTime":"0","summary":"BioAtla公司与GATC Health共同宣布，双方已达成一项价值4000万美元的特殊目的载体（SPV）交易。该资金将专项用于推动Ozuriftamab Vedotin（简称Oz-V）进入针对二线及以上治疗（2L+）口咽鳞状细胞癌（OPSCC）的注册性临床试验阶段。\n此次合作标志着Oz-V在头颈癌治疗领域迈出关键一步。通过设立特殊目的载体，双方旨在高效配置资源，加速该创新疗法的临床开发进程，为复发或转移性口咽鳞状细胞癌患者提供新的治疗希望。\n注册性临床试验的启动将重点评估Oz-V在经治患者群体中的疗效与安全性。若试验结果达到预期，该药物有望为口腔肿瘤治疗领域带来突破性进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BCAB"],"gpt_icon":0},{"id":"1129984900","title":"BioAtla Inc.完成特殊目的载体交易后 将保留Oz-V在所有实体瘤适应症中65%的所有权","url":"https://stock-news.laohu8.com/highlight/detail?id=1129984900","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129984900?lang=zh_cn&edition=full","pubTime":"2025-12-31 20:04","pubTimestamp":1767182646,"startTime":"0","endTime":"0","summary":"BioAtla公司宣布，在完成特殊目的载体（SPV）交易后，该公司将继续持有其候选药物Oz-V在所有实体瘤适应症领域65%的所有权权益。这一安排巩固了BioAtla对该资产的主要控制权，并凸显了公司对其开发前景的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BCAB"],"gpt_icon":0},{"id":"1100304967","title":"BioAtla与Gatc Health携手Inversagen AI 合作开发Cab衰老细胞清除疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=1100304967","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100304967?lang=zh_cn&edition=full","pubTime":"2025-12-31 20:02","pubTimestamp":1767182544,"startTime":"0","endTime":"0","summary":"BioAtla公司宣布，将与Gatc Health共同和人工智能企业Inversagen展开合作，致力于推进Cab衰老细胞清除疗法的研发进程。此次合作旨在整合多方技术优势，加速创新疗法开发。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BCAB"],"gpt_icon":0},{"id":"2594028325","title":"Bioatla, Inc.盘中异动 大幅拉升5.10%报0.704美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2594028325","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594028325?lang=zh_cn&edition=full","pubTime":"2025-12-24 22:43","pubTimestamp":1766587394,"startTime":"0","endTime":"0","summary":"北京时间2025年12月24日22时43分，Bioatla, Inc.股票出现波动，股价快速拉升5.10%。截至发稿，该股报0.704美元/股，成交量20.4072万股，换手率0.35%，振幅2.98%。Bioatla, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。其相关个股中，Indaptus Therapeutics, Inc.、Dermata Therapeutics Inc C/Wts 、Dermata Therapeutics, Inc.涨幅较大，Dermata Therapeutics, Inc.、Indaptus Therapeutics, Inc.、Citius Pharmaceuticals, Inc.较为活跃，换手率分别为1651.59%、921.90%、27.74%，振幅较大的相关个股有Citius Pharmaceuticals, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Indaptus Therapeutics, Inc.，振幅分别为31.73%、20.00%、20.00%。Bioatla, Inc.公司简介：BioAtla Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025122422431497a0a693&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025122422431497a0a693&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCAB","BK4139"],"gpt_icon":0},{"id":"2592148871","title":"Bioatla, Inc.盘中异动 快速跳水5.25%报0.751美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592148871","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592148871?lang=zh_cn&edition=full","pubTime":"2025-12-19 23:10","pubTimestamp":1766157056,"startTime":"0","endTime":"0","summary":"北京时间2025年12月19日23时10分，Bioatla, Inc.股票出现异动，股价快速下挫5.25%。截至发稿，该股报0.751美元/股，成交量23.6666万股，换手率0.40%，振幅6.98%。Bioatla, Inc.股票所在的生物技术行业中，整体涨幅为1.07%。其相关个股中，Gain Therapeutics, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、爱美医疗涨幅较大，Psyence Biomedical Ltd.、In8Bio, Inc.、Neuraxis, Inc.较为活跃，换手率分别为1555.01%、204.28%、108.66%，振幅较大的相关个股有Geovax Labs, Inc.、Gain Therapeutics, Inc.、Lexaria Bioscience Corp.，振幅分别为57.35%、38.67%、27.56%。Bioatla, Inc.公司简介：BioAtla Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219231056953b75c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219231056953b75c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BCAB","GANX"],"gpt_icon":0},{"id":"2586723826","title":"Bioatla, Inc.盘中异动 大幅下挫6.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586723826","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586723826?lang=zh_cn&edition=full","pubTime":"2025-11-25 23:12","pubTimestamp":1764083527,"startTime":"0","endTime":"0","summary":"北京时间2025年11月25日23时12分，Bioatla, Inc.股票出现异动，股价急速下挫6.30%。截至发稿，该股报0.803美元/股，成交量18.8775万股，换手率0.32%，振幅4.56%。Bioatla, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Pharmacyte  Biotech, Inc.、Biovie Inc C/Wts 08/08/2030涨幅较大，Clearmind Medicine Inc.、Lunai Bioworks Inc.、Pasithea Therapeutics Corp.较为活跃，换手率分别为233.20%、163.55%、28.06%，振幅较大的相关个股有Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Osr Holdings Inc C/Wts 09/02/2028 、Lixte Biotechnology Holdings, Inc.，振幅分别为38.79%、33.39%、27.52%。Bioatla, Inc.公司简介：BioAtla Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125231207a710eb4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125231207a710eb4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCAB","BK4139"],"gpt_icon":0},{"id":"1152338366","title":"BioAtla第三季度净亏损为1577.8万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1152338366","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152338366?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:46","pubTimestamp":1763574408,"startTime":"0","endTime":"0","summary":"11月13日 - BioAtla第三季度运营亏损为1378.9万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCAB","BK4139"],"gpt_icon":0},{"id":"2584590856","title":"Bioatla, Inc.股价上涨11.48% 市值涨1214.06万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584590856","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584590856?lang=zh_cn&edition=full","pubTime":"2025-11-19 22:36","pubTimestamp":1763562996,"startTime":"0","endTime":"0","summary":"北京时间2025年11月19日22时36分，Bioatla, Inc.股票出现异动，股价快速拉升11.48%。截至发稿，该股报1.36美元/股，成交量91.6987万股，换手率1.56%，振幅10.66%。Bioatla, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。其相关个股中，Kazia Therapeutics Limited、Biovie Inc C/Wts 08/08/2030、Fulcrum Therapeutics, Inc.涨幅较大，Kazia Therapeutics Limited、Clearmind Medicine Inc.、Can Fite Biopharma Ltd较为活跃，换手率分别为903.28%、82.89%、24.87%，振幅较大的相关个股有Kazia Therapeutics Limited、Fulcrum Therapeutics, Inc.、Annexon, Inc.，振幅分别为13.89%、13.79%、11.41%。Bioatla, Inc.公司简介：BioAtla Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111922363697739ebc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111922363697739ebc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCAB","BK4139"],"gpt_icon":0},{"id":"2582406321","title":"Bioatla, Inc.盘中异动 大幅拉升5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582406321","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582406321?lang=zh_cn&edition=full","pubTime":"2025-11-12 01:15","pubTimestamp":1762881328,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日01时15分，Bioatla, Inc.股票出现波动，股价快速拉升5.20%。截至发稿，该股报0.672美元/股，成交量6.6398万股，换手率0.11%，振幅5.93%。Bioatla, Inc.股票所在的生物技术行业中，整体涨幅为1.36%。其相关个股中，Engene Holdings Inc C/Wts 31/10/2028  Cl A、Engene Holdings Inc.、Xbiotech Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Salarius Pharmaceuticals, Inc.、Aspire Biopharma Holdings, Inc.较为活跃，换手率分别为2773.42%、398.72%、373.63%，振幅较大的相关个股有Engene Holdings Inc C/Wts 31/10/2028  Cl A、Quoin Pharmaceuticals Ltd、Engene Holdings Inc.，振幅分别为75.38%、58.48%、54.91%。Bioatla, Inc.公司简介：BioAtla Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112011529a49a540e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112011529a49a540e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BCAB"],"gpt_icon":0},{"id":"1191722890","title":"BioAtla在2025年ESMO大会上展示了针对治疗抵抗性转移性腺癌的Ba3182一期临床试验的有希望的中期数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1191722890","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191722890?lang=zh_cn&edition=full","pubTime":"2025-10-20 20:01","pubTimestamp":1760961687,"startTime":"0","endTime":"0","summary":"BioAtla在2025年ESMO大会上展示了针对治疗抵抗性转移性腺癌的Ba3182一期临床试验的有希望的中期数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCAB","BK4139"],"gpt_icon":0},{"id":"2575904547","title":"Bioatla, Inc.盘中异动 早盘快速上涨5.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575904547","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575904547?lang=zh_cn&edition=full","pubTime":"2025-10-15 22:06","pubTimestamp":1760537172,"startTime":"0","endTime":"0","summary":"北京时间2025年10月15日22时06分，Bioatla, Inc.股票出现波动，股价大幅拉升5.91%。截至发稿，该股报0.848美元/股，成交量12.6755万股，换手率0.22%，振幅4.99%。Bioatla, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，Genprex, Inc.、奥麦罗制药、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Genprex, Inc.、Scisparc Ltd.、奥麦罗制药较为活跃，换手率分别为800.97%、93.55%、78.91%，振幅较大的相关个股有Genprex, Inc.、Apollomics Inc C/Wts 01/04/2028 、奥麦罗制药，振幅分别为128.99%、103.66%、61.71%。Bioatla, Inc.公司简介：BioAtla Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015220612972fd418&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015220612972fd418&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCAB","BK4139"],"gpt_icon":0},{"id":"2574710900","title":"Bioatla, Inc.盘中异动 早盘快速跳水5.88%报0.960美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2574710900","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574710900?lang=zh_cn&edition=full","pubTime":"2025-10-10 22:59","pubTimestamp":1760108391,"startTime":"0","endTime":"0","summary":"北京时间2025年10月10日22时59分，Bioatla, Inc.股票出现波动，股价大幅下跌5.88%。截至发稿，该股报0.960美元/股，成交量57.4606万股，换手率0.98%，振幅8.58%。Bioatla, Inc.股票所在的生物技术行业中，整体跌幅为0.54%。其相关个股中，Quoin Pharmaceuticals Ltd、Gyre Therapeutics, Inc.、Q32 Bio Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Aditxt, Inc.、Cdt Equity Inc.较为活跃，换手率分别为724.18%、326.69%、72.83%，振幅较大的相关个股有Quoin Pharmaceuticals Ltd、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Briacell Therapeutics Corp C/Wts 26/02/2026，振幅分别为368.75%、39.68%、33.20%。Bioatla, Inc.公司简介：BioAtla Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101022595194c209e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101022595194c209e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCAB","BK4139"],"gpt_icon":0},{"id":"2571136184","title":"Bioatla, Inc.盘中异动 股价大涨5.40%报0.705美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2571136184","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571136184?lang=zh_cn&edition=full","pubTime":"2025-09-29 22:15","pubTimestamp":1759155339,"startTime":"0","endTime":"0","summary":"北京时间2025年09月29日22时15分，Bioatla, Inc.股票出现异动，股价急速拉升5.40%。截至发稿，该股报0.705美元/股，成交量27.648万股，换手率0.47%，振幅4.48%。Bioatla, Inc.股票所在的生物技术行业中，整体涨幅为1.67%。其相关个股中，Merus N.V.、Dogwood Therapeutics, Inc.、Dermata Therapeutics Inc C/Wts 涨幅较大，Dogwood Therapeutics, Inc.、Kala Bio, Inc.、Plus Therapeutics, Inc.较为活跃，换手率分别为1948.64%、207.14%、69.95%，振幅较大的相关个股有Prelude Therapeutics Incorporated、Zura Bio Limited、Dogwood Therapeutics, Inc.，振幅分别为46.60%、40.66%、37.86%。Bioatla, Inc.公司简介：BioAtla Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929221539954c7771&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929221539954c7771&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BCAB"],"gpt_icon":0},{"id":"1101162274","title":"BioAtla, Inc.宣布在与FDA举行富有成效的B类（2期试验结束）会议后，就Ozuriftamab Vedotin治疗口咽鳞状细胞癌临床开发计划发布监管更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1101162274","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101162274?lang=zh_cn&edition=full","pubTime":"2025-09-08 20:01","pubTimestamp":1757332881,"startTime":"0","endTime":"0","summary":"BioAtla, Inc.宣布在与FDA举行富有成效的B类（2期试验结束）会议后，就Ozuriftamab Vedotin治疗口咽鳞状细胞癌临床开发计划发布监管更新。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCAB","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bioatla.com","stockEarnings":[{"period":"1week","weight":-0.3217},{"period":"1month","weight":-0.2006},{"period":"3month","weight":-0.7963},{"period":"6month","weight":-0.6872},{"period":"1year","weight":-0.49},{"period":"ytd","weight":-0.7044}],"compareEarnings":[{"period":"1week","weight":-0.0198},{"period":"1month","weight":-0.0201},{"period":"3month","weight":-0.0194},{"period":"6month","weight":0.0388},{"period":"1year","weight":0.174},{"period":"ytd","weight":-0.014}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Bioatla, Inc.在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，致力于开发用于治疗实体瘤癌症的新型一类基于高特异性和选择性抗体的疗法。该公司的有条件活性生物制剂或CAB利用其在肿瘤生物学方面的专有发现，使其能够靶向以前难以或不可能靶向的已知且经过广泛验证的肿瘤抗原。","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.285575},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.050906},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.05914},{"month":4,"riseRate":0.4,"avgChangeRate":-0.002728},{"month":5,"riseRate":0,"avgChangeRate":-0.198759},{"month":6,"riseRate":0.2,"avgChangeRate":-0.001022},{"month":7,"riseRate":0.4,"avgChangeRate":0.076968},{"month":8,"riseRate":0.6,"avgChangeRate":0.330004},{"month":9,"riseRate":0.2,"avgChangeRate":-0.043527},{"month":10,"riseRate":0.4,"avgChangeRate":-0.027999},{"month":11,"riseRate":0.6,"avgChangeRate":0.166685},{"month":12,"riseRate":0.2,"avgChangeRate":-0.220706}],"exchange":"NASDAQ","name":"BioAtla, Inc.","nameEN":"BioAtla, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BioAtla, Inc.(BCAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BioAtla, Inc.(BCAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BioAtla, Inc.,BCAB,BioAtla, Inc.股票,BioAtla, Inc.股票老虎,BioAtla, Inc.股票老虎国际,BioAtla, Inc.行情,BioAtla, Inc.股票行情,BioAtla, Inc.股价,BioAtla, Inc.股市,BioAtla, Inc.股票价格,BioAtla, Inc.股票交易,BioAtla, Inc.股票购买,BioAtla, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BioAtla, Inc.(BCAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BioAtla, Inc.(BCAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}